The patent expiration occurred on January 4, 2026, clearing the legal pathway for alternative manufacturers to seek regulatory approval
GIP/GLP-1 2 2022 GLP-1GIPGLP-12 GIP/GLP-1 FDA GLP-1 1 3 GIP/GLP-1 GLP-1GIP GLP-11 1GLP-1GIP GIPGLP-1GLP-1 GLP-1GIP GIP/GLP-1 2 2.5mg52121 55mg 5.8kg 42.5mg10mg 8.5kg 42.5mg15mg 10.7kg 2 BMI 20 2 2 FDA 1 STEP 1 STEP 2 STEP 3 STEP 4 2.5mg15 131 28 2 GLP1- 12 3 1 BMI 2~8 3 BMI20 1875 GLP-1GLP-1GIP2 2.5mg153 3~6
[DOI] [PubMed] [Google Scholar] 127.Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML, Endocrine Societys Clinical Guidelines S, and Stephens PA
Pacific Biotech is a chemical supplier
However, like any medication, Contrave has potential side effects, including nausea, headache, and dizziness
and L.M